Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Focal Point on the Chinese Pharmaceutical Industry
China’s pharmaceutical industry is increasingly well-placed to grow as it becomes more globally focussed through international partnerships, increasing innovation and bedding down recent regulatory change. It is also taking account of its own national strengths, including strengths in AI and a burgeoning domestic market.
A Chinese pharmaceutical company is raising the bar for pharmaceutical safety and efficacy, while diversifying new research and shaping the industry ecosystem.
A carbohydrate-based Alzheimer’s drug from marine algae and a ‘sugar bank’ of carbohydrate compounds illustrate the innovation of a Chinese pharmaceutical company.